Antonia Müller

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

Michael R. Bishop, Michael Dickinson, Duncan Purtill et al. · New England Journal of Medicine · 2021 · 520 citations · Full text

Medicine, Hematology, Oncology +9

Developmental Heterogeneity of Cardiac Fibroblasts Does Not Predict Pathological Proliferation and Activation

Shah R. Ali, Sara Ranjbarvaziri, Mahmood Talkhabi et al. · Circulation Research · 2014 · 307 citations

Life Sciences, Cardiology, Cell Biology +12

Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study

Christian van Delden, Oriol Manuel, Pascal Meylan et al. · Clinical Infectious Diseases · 2019 · 305 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 289 citations · Full text

Medicine, Immunology, Oncology +7

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein et al. · Blood · 2010 · 198 citations · Full text

Pharmacy, Immunology, Pathology +14